Profile

Cover photo
378 followers|51,495 views
AboutPostsPhotosVideos

Stream

PhRMA

Shared publicly  - 
 
Loretta shares how her Stage IV lung #cancer diagnosis wasn't a death sentence. Take 3 short minutes to watch this inspirational story that gives us all hope #Hope2Cures http://onphr.ma/1EdiG0N
Loretta was diagnosed with Stage IV lung cancer in February 2003. Now, 12 years after her original diagnosis, Loretta is not only surviving, but thriving.
1
Add a comment...

PhRMA

Shared publicly  - 
 
Our new video explains how high generic utilization rates, competition among brand-name medicines and aggressive tactics by insurers and pharmacy benefit managers to negotiate lower prices all help to keep costs under control.
Too often dialogue on spending on prescription medicines ignores that medicines have consistently accounted for just 10 percent of U.S. health care spending.
1
Add a comment...

PhRMA

Shared publicly  - 
 
Paving the Way for Better Cancer Treatments http://onphr.ma/1CVqd5R highlights the remarkable progress in the fight against cancer.

Researchers are developing new weapons to fight the collection of diseases known as cancer, and discovering new ways to use existing therapies, either alone or in combination with other therapies, to treat various cancers.
Patient participation in #clinicaltrials are critical to ensuring new meds are safe, effective. Yet only 4% of adult cancer patients participate.
1
Add a comment...

PhRMA

Shared publicly  - 
 
Read how gaining Part D coverage reduces hospitalizations & overall spending in Medicare http://onphr.ma/1OQckw3 Written by @allyfunk #MedicareMonday
1
Add a comment...

PhRMA

Shared publicly  - 
 
$349 Billion – that’s how much #PartD actual costs came in under initial projections. Video explains, watch here: http://onphr.ma/1DPHLU8
2
Add a comment...

PhRMA

Shared publicly  - 
 
While grantees are often seen as the face of the 340B program, data shows grantees actually account for just a small share of the overall volume of drug sales in the 340B program. Instead, the program is largely benefiting hospitals that qualify for the program on the basis of their disproportionate share hospital (DSH) percentage.
Which 340B Entities Are Getting Most of the Savings?
1
Add a comment...

PhRMA

Shared publicly  - 
 
The biopharmaceutical industry invests more in R&D, pouring as much as six times more in R&D, relative to sales, than average U.S. manufacturers. 
PhRMA member companies have invested more than $600 billion in the search for new treatments and cures since 2000 – including an estimated $51.2 billion in 2014 alone.
1
1
Add a comment...

PhRMA

Shared publicly  - 
 
PhRMA CEO John Castellani: Stand up for inventors of biologic drugs

The United States faces big decisions that will dictate whether it again takes up the competitive mantle in the world, or whether it will cede leadership to others.

http://onphr.ma/1aefc5n
2
1
Add a comment...

PhRMA

Shared publicly  - 
 
Embracing 21st Century Information Sharing: Defining a New Paradigm for the FDA and Communications with Health Care Professionals. http://onphr.ma/1G6Qdis
The PhRMA Law Department proposes a modified framework for the FDA to consider with regards to information shared by biopharmaceutical companies.
1
Add a comment...

PhRMA

Shared publicly  - 
 
Read "Collaboration for Cures: Teaming Up to Advance Science and Save Lives" to see just what motivates our researchers and scientists on a daily basis. http://onphr.ma/1HN0sZU
Whether it’s family or friends, all of us are potential patients one day. Read Collaboration for Cures to see what motivates researchers & scientists.
1
Add a comment...

PhRMA

Shared publicly  - 
 
The biopharmaceutical industry comes out on top as the country’s manufacturing leader in innovation and economic contributions in a new report from ndp | analytics. While our industry is proud to be in first place, the important takeaway is we must all keep innovating, so we can deliver the highest quality and advanced technologies to the people who depend on them.
The biopharmaceutical industry ranks #1 as the country’s manufacturing leader in innovation and economic contributions, according to a new report.
2
1
Ferchu Fer's profile photo
 
Que novedades hay sobre la tromocitopenia autoinmune. Han hecho investigaciones sobre esto? A mi hijo desde los 5 meses le aplican gammaglobulina porque se le reducen sus plaquetas, pero luego de 15/20 dias de la aplicacion de la gammaglobulina caen nuevamente sus plaquetas. Era sano, y de golpe le apareció esto luego de la aplicacion de  unas vacunas que estan dentro del calendario de vacunacion. Han hechos estudios sobre la trombocitopenia?
 ·  Translate
Add a comment...

PhRMA

Shared publicly  - 
 
A Washington Post article today inaccurately describes the Food and Drug Administration’s (FDA) proposed guidance on distributing peer-reviewed scientific and medical information to healthcare professionals. http://onphr.ma/1D6I7Fw
Washington Post inaccurately describes FDA's proposed guidance on distributing peer-reviewed scientific & medical info to healthcare professionals.
2
Add a comment...
Story
Tagline
Our members create medicines to allow patients to live longer, healthier lives.
Introduction
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures.

PhRMA is a non-profit membership association that does not manufacture or market any pharmaceuticals. If you have questions or concerns about a pharmaceutical product, please contact the manufacturer or the FDA at 1-800-FDA-1088.

*** DISCLAIMER ***

Please don't assume that the Pharmaceutical Research and Manufacturers of America (PhRMA) agrees with or otherwise endorses any particular comment posted on our Google+ Page just because we let it stand.

To be clear, we do not edit or approve any comments or other content submitted by visitors to our site. We do reserve the right, however, to delete any comment or other content that is illegal, abusive, profane, sexually explicit, uses excessive foul language, includes ad hominem attacks, or is otherwise objectionable.

Therefore, please be respectful and responsible in what you write on the PhRMA Google+ Page. We encourage vigorous debate and discussion but urge you to exercise good judgment and common sense when sharing links, images, videos and comments. We never censor content based on political or ideological point of view as we are a non-partisan organization.

We may provide links to other external web sites or resources over which PhRMA does not have control. Such links do not constitute an endorsement by PhRMA of those external web sites. You acknowledge that PhRMA is providing these links to you only as a convenience, and further agree that PhRMA is not responsible for the content of such external web sites or any business dealings you may have with such external web sites.

PhRMA is a non-profit membership association that does not manufacture or market any pharmaceuticals. If you have questions or concerns about a pharmaceutical product, please contact the manufacturer or the FDA at 1-800-FDA-1088.

All Google+ Pages Terms continue to apply. For more information, please read.